| Erythrocytes From Patients With Type 2 Diabetes Induce Endothelial Dysfunction Via Arginase I Z Zhou, A Mahdi, Y Tratsiakovich, S Zahorán, O Kövamees, F Nordin, ... Journal of the American College of Cardiology 72 (7), 769-780, 2018 | 146 | 2018 |
| Sunitinib-induced systemic vasoconstriction in swine is endothelin mediated and does not involve nitric oxide or oxidative stress MHW Kappers, VJ de Beer, Z Zhou, AHJ Danser, S Sleijfer, DJ Duncker, ... Hypertension 59 (1), 151-157, 2012 | 126 | 2012 |
| Red blood cell dysfunction: a new player in cardiovascular disease J Pernow, A Mahdi, J Yang, Z Zhou Cardiovascular research, 2019 | 121 | 2019 |
| Coronary microvascular dysfunction after long-term diabetes and hypercholesterolemia O Sorop, M van den Heuvel, NS van Ditzhuijzen, VJ de Beer, I Heinonen, ... American Journal of Physiology-Heart and Circulatory Physiology 311 (6 …, 2016 | 60 | 2016 |
| Red Blood Cells in Type 2 Diabetes Impair Cardiac Post-Ischemic Recovery Through an Arginase-Dependent Modulation of Nitric Oxide Synthase and Reactive Oxygen Species J Yang, X Zheng, A Mahdi, Z Zhou, Y Tratsiakovich, T Jiao, A Kiss, ... JACC: Basic to Translational Science, 221, 2018 | 58 | 2018 |
| Red blood cell peroxynitrite causes endothelial dysfunction in type 2 diabetes mellitus via arginase A Mahdi, J Tengbom, M Alvarsson, B Wernly, Z Zhou, J Pernow Cells 9 (7), 1712, 2020 | 46 | 2020 |
| Adenosine and adenosine receptor-mediated action in coronary microcirculation Y Zhang, B Wernly, X Cao, SJ Mustafa, Y Tang, Z Zhou Basic Research in Cardiology 116 (1), 1-17, 2021 | 38 | 2021 |
| Alteration of purinergic signaling in diabetes: Focus on vascular function R Zhou, X Dang, RS Sprague, SJ Mustafa, Z Zhou Journal of Molecular and Cellular Cardiology, 2020 | 38 | 2020 |
| Erythrocytes Induce Vascular Dysfunction in COVID-19 A Mahdi, A Collado, J Tengbom, T Jiao, T Wodaje, N Johanssson, ... Available at SSRN 3867953, 0 | 36* | |
| Uridine adenosine tetraphosphate is a novel vasodilator in the coronary microcirculation which acts through purinergic P1 but not P2 receptors Z Zhou, D Merkus, C Cheng, HJ Duckers, AHJ Danser, DJ Duncker Pharmacological Research 67 (1), 10-17, 2013 | 34 | 2013 |
| Infective Endocarditis-A Review of Current Therapy and Future Challenges R Rezar, M Lichtenauer, M Haar, G Hödl, JM Kern, Z Zhou, T Wuppinger, ... Hellenic Journal of Cardiology, 2020 | 33 | 2020 |
| Mechanisms underlying uridine adenosine tetraphosphate-induced vascular contraction in mouse aorta: Role of thromboxane and purinergic receptors Z Zhou, C Sun, SL Tilley, SJ Mustafa Vascular pharmacology 73, 78-85, 2015 | 32 | 2015 |
| Uridine adenosine tetraphosphate and purinergic signaling in cardiovascular system: an update Z Zhou, T Matsumoto, V Jankowski, J Pernow, SJ Mustafa, DJ Duncker, ... Pharmacological Research, 2018 | 31 | 2018 |
| Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory? V Paar, B Wernly, Z Zhou, LJ Motloch, UC Hoppe, A Egle, M Lichtenauer Journal of Thrombosis and Thrombolysis, 1-6, 2020 | 29 | 2020 |
| miR‐499 released during myocardial infarction causes endothelial injury by targeting α7‐nAchR R Zhou, W Huang, X Fan, F Liu, L Luo, H Yuan, Y Jiang, H Xiao, Z Zhou, ... Journal of cellular and molecular medicine 23 (9), 6085-6097, 2019 | 29 | 2019 |
| P2X7 Receptor–Mediated Inflammation in Cardiovascular Disease J Zhou, Z Zhou, X Liu, HY Yin, Y Tang, X Cao Frontiers in Pharmacology 12, 2021 | 28 | 2021 |
| Involvement of NADPH oxidase in A2A adenosine receptor-mediated increase in coronary flow in isolated mouse hearts Z Zhou, U Rajamani, H Labazi, SL Tilley, C Ledent, B Teng, SJ Mustafa Purinergic signalling 11 (2), 263-273, 2015 | 27 | 2015 |
| Practical applications of PCR primers in detection of anammox bacteria effectively from different types of samples Z Zhou, Q Wei, Y Yang, M Li, JD Gu Applied microbiology and biotechnology 102 (14), 5859-5871, 2018 | 25 | 2018 |
| Blunted coronary vasodilator response to uridine adenosine tetraphosphate in post-infarct remodeled myocardium is due to reduced P1 receptor activation Z Zhou, D de Wijs-Meijler, I Lankhuizen, J Jankowski, V Jankowski, ... Pharmacological Research 77, 22-29, 2013 | 24 | 2013 |
| Pulmonary vasoconstrictor influence of endothelin in exercising swine depends critically on phosphodiesterase 5 activity Z Zhou, VJ de Beer, D de Wijs-Meijler, SB Bender, M Hoekstra, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 306 (5 …, 2014 | 21 | 2014 |
Dirk-Jan DunckerHoogleraar Experimentele Cardiologie, Erasmus MC, Universitair Medisch Centrum RotterdamEmail verificata su erasmusmc.nl
